T. Rowe Price Funds SICAV - Global Value Equity Fund I USDRegister to Unlock Ratings |
Performance History | 31/10/2024 |
Growth of 1,000 (GBP) | Advanced Graph |
Fund | 7.2 | 17.5 | 3.4 | 7.6 | 11.5 | |
+/-Cat | 5.5 | -0.8 | 3.0 | -1.7 | 3.1 | |
+/-B’mrk | - | -3.8 | -0.2 | -1.1 | -1.0 | |
Category: Global Large-Cap Value Equity | ||||||
Category Benchmark: Morningstar Gbl Val TME NR USD |
Key Stats | ||
NAV 12/11/2024 | USD 31.43 | |
Day Change | 0.40% | |
Morningstar Category™ | Global Large-Cap Value Equity | |
ISIN | LU0859255472 | |
Fund Size (Mil) 12/11/2024 | USD 783.92 | |
Share Class Size (Mil) 12/11/2024 | USD 447.01 | |
Max Initial Charge | - | |
Ongoing Charge 29/05/2024 | 0.82% |
Investment Objective: T. Rowe Price Funds SICAV - Global Value Equity Fund I USD |
To increase the value of its shares, over the long term, through growth in the value of its investments. |
Returns | |||||||||||||
|
Management | ||
Manager Name Start Date | ||
Sebastien Mallet 28/11/2012 | ||
Marta Yago 01/10/2023 | ||
Inception Date 28/11/2012 |
Advertisement |
Category Benchmark | |
Fund Benchmark | Morningstar Benchmark |
MSCI World NR USD | Morningstar Gbl Val TME NR USD |
Target Market | ||||||||||||||||||||
|
Portfolio Profile for T. Rowe Price Funds SICAV - Global Value Equity Fund I USD | 30/09/2024 |
|
|
Top 5 Holdings | Sector | % |
Microsoft Corp | Technology | 3.04 |
UnitedHealth Group Inc | Healthcare | 2.51 |
Wheaton Precious Metals Corp | Basic Materials | 2.26 |
Broadcom Inc | Technology | 2.02 |
AstraZeneca PLC | Healthcare | 1.93 |
Increase Decrease New since last portfolio | ||
T. Rowe Price Funds SICAV - Global Value Equity Fund I USD |